在接受未受保护的左主冠状动脉支架的患者中,泛免疫炎症值的预后值

Ahmet Karaduman1, Cemalettin Yılmaz2, Mustafa Ferhat Keten1

  • 1Department of Cardiology, Kartal Kosuyolu Research & Education Hospital, Denizer Road, Cevizli Crossroads, No: 2, 34840, Kartal, Istanbul, Turkey.

Biomarkers in medicine
|October 21, 2024
PubMed
概括

泛免疫炎症值 (PIV) 和全身免疫炎症指数 (SII) 的炎症标志物预测左主冠状动脉穿皮冠状动脉干预 (PCI) 后的主要不良心脏事件 (MACE). 对于长期结果,PIV表现出略高于SII的预测能力.